Skip to main content

Advertisement

Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Table 1 Description of included studies

From: How robust are the natural history parameters used in chlamydia transmission dynamic models? A systematic review

Study Setting TD model structure and source Screening uptake source Baseline chlamydia prevalence source Proportion asymptomatic Duration of infection Risk of transmission (baseline)
   No symptoms Symptoms
Adams et al. 2007[14] Comparison of screening strategies, UK Individual based, Turner et al.[24] Studies of opportunistic screening, England Systematic review and UK survey data 95.5% women; 100% men 180 days not seeking treatment 30 days seeking treatment 0.0375 per act
Andersen et al. 2006[15] Home sampling screening with partner notification, Denmark Individual based, Kretzschmar et al.[4, 48] RCT of home sampling, Aarhus Danish surveillance system and observational study in Aarhus 70% women; 50% men 370 days in women; 200 days in men 40 days in women; 33 days in men 0.11 per act
de Vries et al. 2006[17] One off screening, the Netherlands Compartmental, original model Pilot of one off screening, the Netherlands Pilot of one off screening, the Netherlands 70% women; 50% men 1 year 1 month 0.68 assume per partnership
de Vries et al. 2008[16] Repeat systematic screening, the Netherlands As above As above As above As above As above As above As above
Gillespie et al. 2012[18] Opportunistic screening, Ireland Individual based, Turner et al.[24] Pilot of opportunistic screening, Ireland UK data 95.5% women; 100% men 180 days 30 days 0.0375 per act
Low et al. 2007[5] Active screening, UK Individual based, Kretzschmar et al.[4, 48] ClaSS cross sectional study of screening uptake ClaSS project 70% women; 25% men 200 days 40 days in women; 33 days in men 0.122 per act female to male; 0.154 per act male to female
Roberts et al. 2007[19] Register based screening, England Individual based, Kretzschmar et al. and Low et al.[4, 5, 48] ClaSS cross sectional study of screening uptake ClaSS project 70% women; 25% men 200 days 40 days in women; 33 days in men 0.061 per day female to male;
  0.077 per day male to female
Townshend and Turner 2000[21] Three different screening strategies, UK Compartmental, original model Not presented Sample of women presenting for cervical smear, UK 75% women; 50% men 2-3 years Not presented Not presented
Tuite et al. 2012[20] Screening, Canada Compartmental, Fisman et al.[23] Testing patterns from Ontario Public Health Laboratory Annual notifiable disease data, Canada 90% women; 92% men 1 year untreated Not presented Present per partnership transmission probability* partner change rate
Welte et al. 2000[22] GP based opportunistic screening, Netherlands Individual based, Kretzschmar et al.[4, 48] GP pilot study, Amsterdam GP pilot study, Amsterdam 70% women; 50% men Not presented Not presented 0.10 per act
Welte et al. 2005[6] As above As above As above As above Not stated, assume as above 370 days in women; 200 days in men 40 days in women; 33 days in men 0.11 per act